Anti-fungus drug useful for sinus problem
|
Tweet
|
|
Treatment with a nasal spray containing the anti-fungal drug amphotericin B reduces the swelling and inflammation that occurs with chronic rhinosinusitis, a common cause of stuffy nose and facial pain, new research shows.
Amphotericin B is an old drug that can cause serious side effects, particularly to the kidneys. However, when given as a nasal spray, the drug does not get absorbed, effectively avoiding these effects, researchers report in the Journal of Allergy and Clinical Immunology.
The findings, which stem from a study of 30 patients, lend weight to the notion that fungi are involved in the development of chronic rhinosinusitis.
In an interview with Reuters Health, lead author Dr. Jens U. Ponikau, from the Mayo Clinic in Rochester, Minnesota, said that fungi appear to play a key role in chronic rhinosinusitis by causing certain immune cells to show up in the mucous layer of the nose. Once there, the cells release toxic compounds that damage the fungi, but also the surrounding nasal tissue.
Still, the hypothesis that fungi are involved in chronic rhinosinusitis is controversial and it remains to be determined why only certain people develop the condition when nasal fungi are so common, Ponikau noted.
He and his colleagues reasoned that if the immune cells are in the mucous membranes because of the fungi, then maybe reducing the fungi would reduce the inflammation caused by the immune cells and “ultimately improve the patient’s symptoms.”
Compared with inactive “placebo”, 6 months of treatment with amphotericin B nasal spray led to a significant reduction in mucous swelling, as determined by CT scans and other tests. Moreover, such therapy seemed to reduce the number of immune cells present.
“These findings have completely changed the way we approach Sinusitis patients at Mayo,” Ponikau noted, adding that “thousands of chronic rhinosinusitis patients are now being treated with antifungals.”
Larger studies will begin later this year, he said.
SOURCE: Journal of Allergy and Clinical Immunology, January 2005.
Revision date: July 7, 2011
Last revised: by Amalia K. Gagarina, M.S., R.D.
| RELATED STORIES: | ||
| Comments | [ + Post Your Own ] |
Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.
There are no comments for this entry yet. [ + Comment here + ]
We are pleased to let readers post comments about an article. Please increase the credibility of your post by including your full name and email.
All comments are reviewed by our editors before they are posted on the site. Just keep it clean, kids.
- Full Story - - »»»
Exercise tied to lower risk of psoriasis: study
- Full Story - - »»»
Severe Gum Disease, Impotence May Be Linked
- Full Story - - »»»
New Blood Thinner May Lower Chances of Clots in High-Risk Heart Patients: FDA
- Full Story - - »»»
Heart Damage After Chemo Linked to Stress in Cardiac Cells
- Full Story - - »»»
Viewers’ family background affects how they react to MTV shows ‘16 and Pregnant,’ ‘Teen Mom’
- Full Story - - »»»
Weight management in pregnancy with diet is beneficial and safe and can reduce complications
- Full Story - - »»»

